Learning from Synthetic Models of Extracellular Matrix; Differential Binding of Wild Type and Amyloidogenic Human Apolipoprotein A-I to Hydrogels Formed from Molecules Having Charges Similar to Those Found in Natural GAGs

被引:6
作者
Rosu, Silvana A. [1 ,2 ]
Toledo, Leandro [3 ]
Urbano, Bruno F. [3 ]
Sanchez, Susana A. [3 ]
Calabrese, Graciela C. [4 ]
Alejandra Tricerri, M. [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina
[2] Univ Nacl La Plata, Fac Ciencias Med, Calle 60 & 120 S-N, RA-1900 La Plata, Buenos Aires, Argentina
[3] Univ Concepcion, Fac Ciencias Quim, Dept Polimeros, Concepcion, Chile
[4] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Biol Celular & Mol, Junin 954,C1113AAD, Buenos Aires, DF, Argentina
关键词
Amyloidosis; Human apolipoprotein A-I; Synthetic hydrogels; Extracellular matrix; ALZHEIMERS-DISEASE; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; BIGLYCAN; SULFATE; VERSICAN; DECORIN; HEPARIN; PRION;
D O I
10.1007/s10930-017-9728-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Among other components of the extracellular matrix (ECM), glycoproteins and glycosaminoglycans (GAGs) have been strongly associated to the retention or misfolding of different proteins inducing the formation of deposits in amyloid diseases. The composition of these molecules is highly diverse and a key issue seems to be the equilibrium between physiological and pathological events. In order to have a model in which the composition of the matrix could be finely controlled, we designed and synthesized crosslinked hydrophilic polymers, the so-called hydrogels varying the amounts of negative charges and hydroxyl groups that are prevalent in GAGs. We checked and compared by fluorescence techniques the binding of human apolipoprotein A-I and a natural mutant involved in amyloidosis to the hydrogel scaffolds. Our results indicate that both proteins are highly retained as long as the negative charge increases, and in addition it was shown that the mutant is more retained than the Wt, indicating that the retention of specific proteins in the ECM could be part of the pathogenicity. These results show the importance of the use of these polymers as a model to get deep insight into the studies of proteins within macromolecules.
引用
收藏
页码:374 / 383
页数:10
相关论文
共 30 条
[1]  
[Anonymous], 2014, INTRO FLUORESCENCE
[2]   Role of Proteoglycans and Glycosaminoglycans in the Pathogenesis of Alzheimer's Disease and Related Disorders: Amyloidogenesis and Therapeutic Strategies-A Review [J].
Ariga, Toshio ;
Miyatake, Tadashi ;
Yu, Robert K. .
JOURNAL OF NEUROSCIENCE RESEARCH, 2010, 88 (11) :2303-2315
[3]   Differential Effects on Light Chain Amyloid Formation Depend on Mutations and Type of Glycosaminoglycans [J].
Blancas-Mejia, Luis M. ;
Hammernik, Jared ;
Marin-Argany, Marta ;
Ramirez-Alvarado, Marina .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (08) :4953-4965
[4]   Antithrombin and first complement protein recognize the same active heparin fraction [J].
Calabrese, GC ;
Recondo, EF ;
De Recondo, MEF .
THROMBOSIS RESEARCH, 2002, 105 (06) :537-541
[5]   Endothelial protection by high-density lipoproteins - From bench to bedside [J].
Calabresi, L ;
Gomaraschi, M ;
Franceschini, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (10) :1724-1731
[6]   Protein misfolding, functional amyloid, and human disease [J].
Chiti, Fabrizio ;
Dobson, Christopher M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :333-366
[7]   Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases [J].
Díaz-Nido, J ;
Wandosell, F ;
Avila, J .
PEPTIDES, 2002, 23 (07) :1323-1332
[8]   Amyloid-β interactions with chondroitin sulfate-derived monosaccharides and disaccharides -: Implications for drug development [J].
Fraser, PE ;
Darabie, AA ;
McLaurin, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) :6412-6419
[9]   Engineering hydrogels as extracellular matrix mimics [J].
Geckil, Hikmet ;
Xu, Feng ;
Zhang, Xiaohui ;
Moon, SangJun ;
Demirci, Utkan .
NANOMEDICINE, 2010, 5 (03) :469-484
[10]   Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries [J].
Gutierrez, P ;
OBrien, KD ;
Ferguson, M ;
Nikkari, ST ;
Alpers, CE ;
Wight, TN .
CARDIOVASCULAR PATHOLOGY, 1997, 6 (05) :271-278